I believe we have 20 patients in the European EFS. In addition one compassionate use. We’ve now had 2 Valve in Valve. We have also now had patients operated on for the USA EFS.
A total of 25 with all feedback showing excellent results to date, including those performed over a year ago.
With 13 more for the USA EFS and probably a few more Viv won’t be long now and we will have 50 done which will start to provide the market with some sense of safety risk profile.
Ann: Exceptional Results in Second Valve-in-Valve Case, page-21
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$6.00 |
Change
-0.030(0.50%) |
Mkt cap ! $92.99M | |||
| Open | High | Low | Value | Volume |
| $6.01 | $6.03 | $5.84 | $85.53K | 14.32K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 333 | $6.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.25 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 23/06/2025 (20 minute delay) ? |
| AVR (ASX) Chart |